Expert Opinion on Investigational Drugs - sprookjes - yvandenbroek - TriplyDB

Expert Opinion on Investigational Drugs

Expert Opinion on Investigational Drugs

http://www.wikidata.org/entity/Q5421208

Expert_Opinion_on_Investigational_Drugs Expert_Opinion_on_Investigational_Drugs Q5421208

about

Clinical immunologic approaches for the treatment of Alzheimer's disease Potential therapeutic use of melatonin in migraine and other headache disorders The benzodiazepine binding site of GABA A receptors as a target for the development of novel anxiolytics Current and potential pharmacological treatments for obsessive-compulsive disorder The immunotherapeutic potential of melatonin Cyclin-dependent kinase inhibitor therapy for hematologic malignancies Cixutumumab Investigational drugs to treat methicillin-resistant Staphylococcus aureus Investigational peptide and peptidomimetic μ and δ opioid receptor agonists in the relief of pain Glial modulators: a novel pharmacological approach to altering the behavioral effects of abused substances Targeting Mcl-1 for the therapy of cancer Targeting memory processes with drugs to prevent or cure PTSD Sapacitabine for cancer GLYX-13, an NMDA receptor glycine site functional partial agonist enhances cognition and produces antidepressant effects without the psychotomimetic side effects of NMDA receptor antagonists Mechanisms of drug resistance in kinases.Ebselen: prospective therapy for cerebral ischaemia Necatoriasis: treatment and developmental therapeutics Update on acute coronary syndromes and implications for therapy Effects of ADP-receptor antagonism beyond traditional inhibition of platelet aggregation The potential role of non-steroidal anti-inflammatory drugs in treating Alzheimer's disease Advances in the development of thrombin inhibitors Advances in pharmacological treatment of migraine Nitric oxide-modulating agents for gastrointestinal disorders Nephrological and obstetric complications of the antiphospholipid syndrome Developing pharmaceutical treatments for peripheral artery disease New antithrombotic drugs on the horizon Peramivir (BCX-1812, RWJ-270201): potential new therapy for influenza Neuroprotective agents in traumatic brain injury Prasugrel Novel therapies for the prevention of stroke Oxytrex: an oxycodone and ultra-low-dose naltrexone formulation Novel pharmacological approaches for the treatment of acne vulgaris The use of herbal medicines in early drug development for the treatment of HIV infections and AIDS Triple uptake inhibitors: therapeutic potential in depression and beyond Early experience with novel immunomodulators for cancer treatment Current investigational drugs for major depression Sunitinib in solid tumors Alvimopan Tesofensine – a novel potent weight loss medicine Voltage-gated cation channel modulators for the treatment of stroke

P1433

Q22241380-E379F0E2-AA7A-4E71-B7EE-8B8BB2DEC0F9 Q22306023-ED9F0A3A-E670-4900-91B6-682FA311F265 Q22306024-47E40DA5-1529-4BB4-BCE4-571AE562B4E9 Q22306025-63E67DA1-B40D-4110-820C-E3EC63537A19 Q22306026-3A9330C3-D7EC-43CA-AEC4-E68C150B86E8 Q24561485-06E30EA7-1944-4203-A6F7-8702ACECAC9C Q24609058-8EC76E76-1627-48C7-8B0F-769A3AD3225B Q26780246-7BA89A76-D0EC-4A38-8E67-A4102A6BCE32 Q26863769-EAA0BE7C-BE77-4360-B1E0-3E6B4C4FB6B9 Q27003932-EE93BB95-28FA-4DF4-A3FE-8202954C8669 Q27011870-60F52BF6-C37D-4B68-B813-519012B9D022 Q27016155-E4A3D51F-3C36-4B37-A723-76EF6FDAF3F6 Q27024675-F5C22067-6B4B-4EE3-9DDD-B33FD9D916A2 Q27025974-AED9C96F-0DF0-44B6-BB14-62543F9B9802 Q27692567-8D990089-EF43-40F8-B89D-0ADF4D9E6B2C Q28142842-74A53A95-D214-4A18-9C07-7D64E9C066E8 Q28142850-F15743B5-3389-44A9-96FB-A8163A2D4549 Q28166274-6C523194-0BD8-4809-BED3-CC896E5FCEF1 Q28168698-0C70E5ED-99BB-468C-AFEC-E6DC0580D1BC Q28171273-1D49046B-8A66-469A-AEB6-0A6E8D1C5B57 Q28182480-6A236798-4905-4F2F-84B0-242ACB8DEB69 Q28192002-24A31304-53DD-4F1D-A5FF-085E0C13E827 Q28192955-4C772583-A7D6-4671-8883-DF0724F60F4C Q28193094-605E1BC1-3AA0-439F-8E53-556D1E99F8CF Q28194590-91FD824C-0D90-40F8-9BF3-E6E89308B77B Q28195790-787F464C-8E3F-4F7A-B53A-C40DAEAE2151 Q28201381-9F274781-39D8-4127-BF19-646CC3819ADD Q28209606-BEA4A37B-2BFA-40F7-A3EF-FD78F29DE08E Q28210429-2D609859-7A84-472F-8C34-FCBB976D1688 Q28210724-324BF92D-0DA7-49D0-9D65-F83A3605FA0A Q28239922-12937175-BB85-4042-B643-48AF2E8E29C8 Q28241186-06B100B1-BAB5-45A9-887F-F6610A5571A5 Q28241719-D4497610-CB04-4077-9CFE-8137F440EE46 Q28241732-0A4261DC-0088-4190-AE25-B64002BC6815 Q28241744-86A88B22-05ED-4CDE-A7F7-DD41542C72DB Q28244223-11D58F19-5864-475D-98E9-CEAE8E6895B2 Q28245467-3C6A081A-2D8D-495E-82D2-9FD24E9FCE6F Q28249359-4D0A969E-FD8B-4BAB-A383-1E4B00FF2F49 Q28249593-F65D1543-5E14-4A71-A0D6-BF2C5486DFAE Q28253754-3DDF7EC7-B3A6-4F26-B5BD-44067F598298

P1433

Expert Opinion on Investigational Drugs

http://www.wikidata.org/entity/Q5421208

description

begutachtete wissenschaftliche Zeitschrift

@de

peer-reviewed scientific journal

@en

revista científica

@es

rivista scientifica

@it

vědecký časopis

@cs

wetenschappelijk tijdschrift van Informa

@nl

рецензований науковий журнал

@uk

वैज्ञानिक पत्रिका

@hi

英语期刊

@zh

name

Expert Opinion on Investigational Drugs

@ast

Expert Opinion on Investigational Drugs

@da

Expert Opinion on Investigational Drugs

@de

Expert Opinion on Investigational Drugs

@en

Expert Opinion on Investigational Drugs

@es

Expert Opinion on Investigational Drugs

@fi

Expert Opinion on Investigational Drugs

@fr

Expert Opinion on Investigational Drugs

@it

Expert Opinion on Investigational Drugs

@nb

Expert Opinion on Investigational Drugs

@nl

type

label

Expert Opinion on Investigational Drugs

@ast

Expert Opinion on Investigational Drugs

@da

Expert Opinion on Investigational Drugs

@de

Expert Opinion on Investigational Drugs

@en

Expert Opinion on Investigational Drugs

@es

Expert Opinion on Investigational Drugs

@fi

Expert Opinion on Investigational Drugs

@fr

Expert Opinion on Investigational Drugs

@it

Expert Opinion on Investigational Drugs

@nb

Expert Opinion on Investigational Drugs

@nl

prefLabel

Expert Opinion on Investigational Drugs

@ast

Expert Opinion on Investigational Drugs

@da

Expert Opinion on Investigational Drugs

@de

Expert Opinion on Investigational Drugs

@en

Expert Opinion on Investigational Drugs

@es

Expert Opinion on Investigational Drugs

@fi

Expert Opinion on Investigational Drugs

@fr

Expert Opinion on Investigational Drugs

@it

Expert Opinion on Investigational Drugs

@nb

Expert Opinion on Investigational Drugs

@nl

P101

Q5421208-d215c164-4d70-9d59-0f85-c7fedb77c576

P1055

Q5421208-9A6DAC8D-C73C-4EE3-976D-085B6DC5371D

P1058

Q5421208-C09A9E25-794E-44F0-838B-9E8A3BF9DA39

P1156

Q5421208-E1ADB571-B7F7-47EE-9240-32937ACB15B6

P1159

Q5421208-121CAD2D-F4F9-4BEF-9736-29AAE2FFDE33

P123

Q5421208-FDB4420B-8E7B-4373-B79F-B6C07BA1AB5C

P1240

Q5421208-D9CAFF39-D51B-4E72-91F4-560D2EE09903

P1250

Q5421208-EC5CA0BF-AD07-4B37-B6DC-24D33F0EB7F8

P1277

Q5421208-9125B7D8-5202-4B13-BB85-D4C3F16E517B

P1476

Q5421208-32617F71-7105-493B-BB8A-D8B9A10133F5

P236

Q5421208-8CE9BF06-F685-46A4-A0F4-8E1126D1306D

Q5421208-9C32A835-3127-43EC-A1B4-39654FEBDEBA

P243

Q5421208-28D2514F-8CD6-47B8-A3CE-EEAA1500F79E

P31

Q5421208-C5EFAA2B-0DDC-41F9-9C67-9FAF1A99FBC6

P3181

Q5421208-8C5DF20B-D9EB-4E70-973B-7CAE53DBB9D0

P407

Q5421208-5F802254-DCBD-488A-A997-8AF6AF8F7012

P4616

Q5421208-F55F18FE-4A8D-414D-BBEA-694B3F05A980

P495

Q5421208-0AD3B483-80CD-4F9B-B362-9F2EA14F1165

P571

Q5421208-2E09FC3B-96A4-44E9-A00A-C227E18DDA8C

P6981

Q5421208-7542AFC3-CAFC-4C30-B3CE-138BC2D9EAF3

Q5421208-DD0B6B69-B3FF-496B-87C3-9F0667B4B3D1

P856

Q5421208-39E2D386-E4F8-4F34-A223-A7CCB435F4F0

P921

Q5421208-119720F1-E03E-4776-8EF1-1925F7935715

P236

urn:ISSN:1354-3784

urn:ISSN:1744-7658

P243

P3181

P4616

P101

pharmaceutical science

P1055

9434197

http://www.w3.org/2001/XMLSchema#string

P1058

14761

http://www.w3.org/2001/XMLSchema#string

P1156

21351

http://www.w3.org/2001/XMLSchema#string

P1159

EOIDER

http://www.w3.org/2001/XMLSchema#string

P123

P1240

1

http://www.w3.org/2001/XMLSchema#string

P1250

12015

http://www.w3.org/2001/XMLSchema#string

P1277

55973

http://www.w3.org/2001/XMLSchema#string

P1476

Expert Opinion on Investigational Drugs

@en

P236

1354-3784

http://www.w3.org/2001/XMLSchema#string

1744-7658

http://www.w3.org/2001/XMLSchema#string

P243

30379431

http://www.w3.org/2001/XMLSchema#string

P31

scientific journal

P3181

8802

http://www.w3.org/2001/XMLSchema#string

P407

P4616

4249

http://www.w3.org/2001/XMLSchema#string

P495

Amatnhom Mäcŋaknhom

P571

1992-01-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P6981

2043267

http://www.w3.org/2001/XMLSchema#string

2890053

http://www.w3.org/2001/XMLSchema#string

P856